Advertisement

International Journal of Behavioral Medicine

, Volume 12, Issue 4, pp 218–226 | Cite as

Cognitive behavioral stress management effects on mood, social support, and a marker of antiviral immunity are maintained up to 1 year in HIV-infected gay men

  • Adam W. Carrico
  • Michael H. Antoni
  • Deidre B. Pereira
  • Mary Ann Fletcher
  • Nancy Klimas
  • Suzanne C. Lechner
  • Neil Schneiderman
Article

Abstract

Numerous herpesvirus infections are associated with clinically relevant outcomes as well as an accelerated HIV replication rate and subsequent disease progression. Stress managementinterventionsmayimprovemarkersofcellularimmunecontroloverlatent herpesvirus infections and these changes appear to be mediated by perceptions of increased social support availability. We examined the effects ofagroup-based cognitive behavioral stress management (CBSM) intervention on distress, dysphoria, perceived socialsupport,andherpesvirus immunoglobulin G (IgG) antibody titers during the 6to 12 months following the intervention. Of those who were initially randomized, 49 HIV-infected men were followed during the 6-to 12-month period after randomization to either a 10-week CBSM intervention (n=31) or amodified wait-list control condition (n = 18). Measures of distress, dysphoria, social support, and blood samples for herpesvirus Ig Gtiters were taken at baseline,immediately following CBSM and at-6-to 12-month follow-up. Men in CBSM displayed maintenance of previously observed intervention effects on dysphoria, reliable alliance support, and herpesvirus IgG antibody titers (i.e., Epstein-Barr virus capsid antigen; EBV-VCA). Intervention-related changes in EBV-VCA were unrelated to changes in lymphocyte subsets (i.e., CD4+, CD8+, and CD4+:CD8+) or changes in measures of dysphoria and social support during the investigation period. Data indicate that HIV-infected men participating in a CBS Mintervention maintain better psychosocial status and immunologic control of latent EBV infection up to 1 year after its conclusion.

Key words

depression social support intervention HIV herpesvirus 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.Google Scholar
  2. Antoni, M. H., Cruess, D. G., Cruess, S., Lutgendorf, S., Kumar, M., Ironson, G., et al. (2000). Cognitive behavioral stress management intervention effects on anxiety, 24-hour urinary norepinephrine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. Journal of Consulting and Clinical Psychology, 68, 31–45.PubMedCrossRefGoogle Scholar
  3. Antoni, M. H., Cruess, D. G., Klimas, N., Maher, K., Cruess, S., Kumar, M., et al. (2002). Stress management and immune system reconstitution in symptomatic HIV-infected gay men over time: Effects on transitional naïve T cells (CD4+ CD45RA+CD29+). American Journal of Psychiatry, 159, 143–144.PubMedCrossRefGoogle Scholar
  4. Antoni, M. H., Lutgendorf, S., Ironson, G., Fletcher, M. A., & Schneiderman, N. (1996). CBSM intervention effects on social support, coping, depression, and immune function in symptomatic HIV-infected gay men. Psychosomatic Medicine, 58, 86.Google Scholar
  5. Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51, 1173–1182.PubMedCrossRefGoogle Scholar
  6. Beck, A. I., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, E. (1961). An inventory for measuring depression. Archives of General Psychiatry, 47, 720–725.Google Scholar
  7. Bower, J. E., Kemeny, M. E., & Fawzy, F. I. (2002). Group interventions for individuals with serious medical illness. In M. A. Chesney & M. A. Antoni (Eds.), Innovative approaches to health psychology: Prevention and treatment lessons from AIDS. Washington, DC: American Psychological Association.Google Scholar
  8. Byrnes, D., Antoni, M. H., Goodkin, K., Efantis-Potter, J., Simon, T., Munajj, J., et al. (1998) Stressful events, pessimism, natural killer cell cytotoxicity, and cytotoxic/suppressor T-cells in HIV+ Black women at risk for cervical cancer. Psychosomatic Medicine, 60, 714–722.PubMedGoogle Scholar
  9. Cruess, S., Antoni, M., Cruess, D., Fletcher, M. A., Ironson, G., Kumar, M., et al. (2000). Reduction in herpes simplex virus type 2 antibody titers after cognitive behavioral stress management and relationships with neuroendocrine function, relaxation skills, and social support in HIV-positive gay men. Psychosomatic Medicine, 62, 828–837.PubMedGoogle Scholar
  10. Cruess, S., Antoni, M., Kilbourn, K., Ironson, G., Klimas, N., Fletcher, M. A., et al. (2000). Optimism, distress, and immunologic status in HIV-infected gay men following Hurricane Andrew. International Journal of Behavioral Medicine, 7, 160–182.CrossRefGoogle Scholar
  11. Cutrona, C., & Russell, D. (1987). The provisions of social relationships and adaptation to stress. In W. H. Jones & D. Perlman (Eds.), Advances in personal relationships (Vol. 1, pp. 33–67). Greenwich, CT: JAI.Google Scholar
  12. Esterling, B. A., Antoni, M. H., Schneiderman, N., Carver, C. S., La Perriere, A., Ironson, G., et al. (1992). Psychosocial modulation of antibody to Epstein-Barr viral capsid antigen and human herpes virus type-6 in HIV-1 infected and at risk gay men. Psychosomatic Medicine, 54, 354–371.PubMedGoogle Scholar
  13. Fletcher, M. A., Maher, K., Patarca, R., & Klimas, N. (2000). Comparative analysis of lymphocytes in lymph nodes and peripheral blood of patients with chronic fatigue syndrome. Journal of the Chronic Fatigue Syndrome, 7, 65–75.CrossRefGoogle Scholar
  14. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.PubMedCrossRefGoogle Scholar
  15. Greenspan, J. S., Lennette, E. T., Abrams, D. I., Conant, M. A., Petersen, V., & Freese, U. K. (1985). Replication of Epstein-Barr virus within the epithelial cells of oral “hairy” leukoplakia, and AIDS-associated lesion. New England Journal of Medicine, 313, 1564–1671.PubMedGoogle Scholar
  16. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry, 23, 56–62.CrossRefGoogle Scholar
  17. Kemeny, M. E., & Laudenslager, M. L. (1999). Beyond stress: The role of individual difference factors in psychoneuroimmunology. Brain, Behavior, and Immunity, 13, 73–75.PubMedCrossRefGoogle Scholar
  18. Kendall, P. C., Hollon, S. D., Beck, A. T., Hammen, C. L., & Ingram, R. F. (1987). Issues and recommendations regarding use of the Beck Depression Inventory. Cognitive Theraphy and Research, 11, 289–299.CrossRefGoogle Scholar
  19. Kenney, S., Kamine, J., Markovitz, D., Fenrick, R., & Pagano, J. (1988). An Epstein-Barr virus immediate-early gene product trans-activates gene expression from human immunodeficiency virus long terminal repeat. National Academy of Sciences USA, 85, 1652–1656.CrossRefGoogle Scholar
  20. Kiecolt-Glaser, J. K., McGuire, L., Robles, T. F., & Glaser, R. (2002). Psychoneuroimmunology: Psychological influences on immune function and health. Journal of Consulting and Clinical Psychology, 70, 537–547.PubMedCrossRefGoogle Scholar
  21. Laurence, J. (1990). Molecular interactions among herpesviruses and human immunodeficiency virus. Journal of Infectious Diseases, 162, 338–346.PubMedGoogle Scholar
  22. Leserman, J., Petitto, J. M., Golden, R. N., Gaynes, B. N., Gu, H., Perkins, D. O., et al. (2000). Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS. American Journal of Psychiatry, 157, 1221–1228.PubMedCrossRefGoogle Scholar
  23. Lutgendorf, S. K., Antoni, M. H., Ironson, G., Klimas, N., Kumar, M., Starr, K., et al. (1997). Cognitive behavioral stress management intervention decreases dysphoria and herpes simplex virus-type 2 titers in symptomatic HIV-seropositive gay men. Journal of Consulting and Clinical Psychology, 65, 23–31.CrossRefGoogle Scholar
  24. Lutgendorf, S. K., Antoni, M. H., Ironson, G., Starr, K., Costello, N., Zuckerman, M., et al. (1998). Changes in cognitive coping skills and social support during cognitive behavioral stress management intervention and distress outcomes in symptomatic human immunodeficiency virus-seropositive gay men. Psychosomatic Medicine, 60, 204–214.PubMedGoogle Scholar
  25. Mallon, R., Borkowski, J., Albin, R., Pepitoni, S., Schwartz, J., & Kieff, E. (1990). The Epstein-Barr virus BZLF1 gene product activates human immunodeficiency virus type 1 5 long terminal repeat. Journal of Virology, 64, 6282–6285.PubMedGoogle Scholar
  26. Maraglith, M., Sarov, B., Sarov, I., Rinaldo, C., Detels, R., Phair, J., et al. (1990). Serum IgG and IgA antibodies specific to Epstein-Barr virus capsid antigen in a longitudinal study of human immunodeficiency virus infection and disease progression in homosexual men. AIDS Research and Human Retroviruses, 6, 607–615.Google Scholar
  27. McNair, D. M., Lorr, M., & Droppleman, L. F. (1971). EITS manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service.Google Scholar
  28. Miller, G. E., & Cohen, S. (2001). Psychological interventions and the immune system: A meta-analytic review and critique. Health Psychology, 20, 47–63.PubMedCrossRefGoogle Scholar
  29. Miller, G. E., & Cole, S. W. (1998). Social relationships and the progression of human immunodeficiency virus infection: A review of the evidence and possible underlying mechanisms. Annals of Behavioral Medicine, 20, 181–189.PubMedCrossRefGoogle Scholar
  30. Montaginer, L., Gruest, J., Chamaret, S., Douget, C., Alxer, C., Guetard, D., et al. (1984). Adaptation to lymphadenopathy virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. Science, 225, 63–66.CrossRefGoogle Scholar
  31. Quinlivan, E. B., Holley-Guthrie, E., Mar, E. C., Smith, M. S., & Kennedy, S. (1990). The Epstein-Barr virus BRLF1 Immediate-early gene product transactivates human immunodeficiency virus type 1 long term repeat by a mechanism which is enhancer independent. Journal of Virology, 64, 1817–1820.PubMedGoogle Scholar
  32. Reed, G. M., Kemeny, M. E., Taylor, S. E., & Visscher, B. R. (1999). Negative HIV-specific expectancies and AIDS-related bereavement as predictors of symptom onset in HIV-positive gay men. Health Psychology, 18, 354–363.PubMedCrossRefGoogle Scholar
  33. Reed, G. M., Kemeny, M. E., Taylor, S. E., Wang, H. Y. J., & Visscher, B. R. (1994). Realistic acceptance as a predictor of decreased survival time in gay men with AIDS. Health Psychology, 13, 299–307.PubMedCrossRefGoogle Scholar
  34. Rinaldo, C. R. (1990). Immune suppression by herpesviruses. Annual Review of Medicine, 41, 331–338.PubMedCrossRefGoogle Scholar
  35. Sarason, I. G., Johnson, J., & Siegal, J. M. (1978). Assessing the impact of life changes: Development of the Life Experiences Survey. Journal of Consulting and Clinical Psychology, 46, 932–946.PubMedCrossRefGoogle Scholar
  36. Schneiderman, N., Antoni, M. H., & Ironson, G. (1997). Cognitive-behavioral stress management in and secondary prevention in HIV/AIDS. Psychology and AIDS Exchange, 22, 1–8.Google Scholar
  37. Shao, J. Y., Li, Y. H., Gao, H. Y., Wu, Q. L., Cui, N. J., Zhang, L., et al. (2004). Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer, 100, 1162–1170.PubMedCrossRefGoogle Scholar
  38. Spitzer, R., Williams, J. B. W., Gibbon, M., & First, M. (1988). Structured clinical interview for DSM-III R: Nonpatient version for HIV studies SCID-NP HIV. New York: Biometrics Department, New York Psychiatric Institute.Google Scholar
  39. Stevens, S. J. C., Blank, B. S. N., Smits, P. H. M., Meenhorst, P. L., & Middeldorp, J. M. (2002). High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: Correlation with antiretroviral therapy and quantitative EBV serology. AIDS, 16, 993–1001.PubMedCrossRefGoogle Scholar
  40. Williams, J., Rabkin, J., & Remien, R. (1991). Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection: II. Standardized clinical assessment of current and lifetime psychopathology. Archives of General Psychiatry, 48, 124–130.PubMedGoogle Scholar
  41. Ziegler, J. L., Beckstead, J. A., Volberding, P. A., Abrams, D. I., Levine, A.M., Lukes, R. J., et al. (1984). Non-Hodgkin’s lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immune deficiency syndrome. New England Journal of Medicine, 311, 565–570.PubMedCrossRefGoogle Scholar
  42. Zuckerman, M., & Antoni, M. H. (1995). Social support and its relationship to psychological, physical health and immune variables in HIV infection. Clinical Psychology and Psychotherapy, 2, 210–219.CrossRefGoogle Scholar

Copyright information

© International Society of Behavioral Medicine 2005

Authors and Affiliations

  • Adam W. Carrico
    • 1
  • Michael H. Antoni
    • 2
  • Deidre B. Pereira
    • 3
  • Mary Ann Fletcher
    • 4
  • Nancy Klimas
    • 4
  • Suzanne C. Lechner
    • 5
  • Neil Schneiderman
    • 6
  1. 1.Department of PsychologyUniversity of MiamiFloridaUSA
  2. 2.Department of Psychology, Department of PsychiatryUniversity of MiamiFloridaUSA
  3. 3.Department of Psychology, Department of Obstetrics and GynecologyUniversity of MiamiFloridaUSA
  4. 4.Department of MedicineUniversity of MiamiFloridaUSA
  5. 5.Department of PsychiatryUniversity of MiamiFloridaUSA
  6. 6.Department of Psychology, Department of Psychiatry, Department of MedicineUniversity of MiamiFloridaUSA

Personalised recommendations